Cadila Healthcare enters pact with Korean Enzychem for DNA Covid-19 vaccine

Cadila will provide the manufacturing license and transfer  Covid-19 plasmid DNA vaccine technology to Enzychem Lifesciences, while the latter will manufacture and commercialise the jab under the Zydus trademark

Related Keywords

Enzychem Lifesciences , ,Cadila Helathcare ,Plasmid Dna Vaccine ,